These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9811516)

  • 21. Distribution of hepatitis C virus RNA in whole blood of patients with HCV infection and HBV-HCV coinfection.
    Mazurek U; Wilczok T; Mazur W; Bednarek I; Strzałka B; Jurzak M; Laskowska-Lepiarczyk E; Gonciarz Z
    Med Sci Monit; 2002 Feb; 8(2):CR125-30. PubMed ID: 11859286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Poland.
    Brojer E
    Vox Sang; 2005 Nov; 89(4):267-8. PubMed ID: 16262764
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis C virus RNA quantification by the COBAS AmpliPrep/COBAS TaqMan System: averages do not tell the whole story.
    Gelderblom HC; Beld MG
    J Clin Virol; 2007 Aug; 39(4):326-7. PubMed ID: 17600765
    [No Abstract]   [Full Text] [Related]  

  • 24. Status of NAT screening for HCV, HIV and HBV--experiences of the German Red Cross Blood Donation Services.
    Seifried E; Findhammer S; Roth WK
    Dev Biol (Basel); 2002; 108():23-7. PubMed ID: 12220139
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of the International Consortium for Blood Safety (ICBS) HCV panels.
    Diaz S; Liu P; Kuhnert WL; Healy M; Prince AM; El-Nageh MM
    East Mediterr Health J; 2008; 14(2):427-37. PubMed ID: 18561736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
    Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
    Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lyophilized standards for the calibration of real time PCR assay for hepatitis C virus RNA.
    Wang LN; Wu JM; Deng W; Shen ZY; Chen WX; Li JM
    Chin Med J (Engl); 2006 Nov; 119(22):1910-4. PubMed ID: 17134591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HCV and HIV-1 donor screening using nucleic acid amplification technique (NAT).
    O'Riordan J; Williams P; Donnellan J
    Vox Sang; 2005 Nov; 89(4):266. PubMed ID: 16262763
    [No Abstract]   [Full Text] [Related]  

  • 29. [The applicability of molecular biology in environmental virological research].
    Divizia M; Panà A
    Ann Ig; 1999; 11(6):461-6. PubMed ID: 10596435
    [No Abstract]   [Full Text] [Related]  

  • 30. Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992.
    Cagle HH; Jacob J; Homan CE; Williams JL; Christensen CJ; McMahon BJ
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):125-30. PubMed ID: 17283296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with PCR screening.
    Sun R; Jayakar H; Yeh S; Mendoza M; Wisbeski MH; Iszczyszyn W; Dragon EA
    Dev Biol (Basel); 2000; 102():81-91. PubMed ID: 10794093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfusion-transmitted viruses.
    Wright-Kanuth MS; Smith LA
    Clin Lab Sci; 2003; 16(4):221-9. PubMed ID: 14626440
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C virus RNA detection by in situ RT-PCR in formalin-fixed paraffin-embedded liver tissue. Comparison with serum and tissue results.
    Biagini P; Benkoel L; Dodero F; de Lamballerie X; Chamlian V; Nouhou H; Gerolami V; de Micco P; Chamlian A
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL167-71. PubMed ID: 11936864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HCV RNA assessment by PCR technique for screening post-transfusion HCV infection among blood donors].
    Xing W; Xu H; Ma R; Zheng H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):211-2. PubMed ID: 12113682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia.
    Al-Kubaisy WA; Al-Naib KT; Habib M
    East Mediterr Health J; 2006; 12(1-2):204-10. PubMed ID: 17037239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
    Williams JL; Cagle HH; Christensen CJ; Fox-Leyva LK; McMahon BJ
    Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1.
    Candotti D; Temple J; Owusu-Ofori S; Allain JP
    J Virol Methods; 2004 Jun; 118(1):39-47. PubMed ID: 15158067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The programme of the World Health Organization in medical virology.
    Cockburn WC
    Prog Med Virol; 1973; 15():159-204. PubMed ID: 4348874
    [No Abstract]   [Full Text] [Related]  

  • 40. Genomic screening for blood-borne viruses in transfusion settings.
    Lee HH; Allain JP
    Vox Sang; 1998; 74 Suppl 2():119-23. PubMed ID: 9704433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.